Christine Loh

Dr. Christine Loh is Senior Vice President, Head of Biology at Nimbus. Prior to joining Nimbus, she served as Vice President of Translational Medicine at Kymera Therapeutics, where she facilitated biomarker strategy, patient selection and resource-building initiatives to transition pipeline programs into clinical development. Previously, Christine was the Executive Director of Research at Bioverativ, leading a group focused on hemophilia and sickle cell disease. During that time, she also helped progress the spinout of Bioverativ from Biogen, where she had spent five years directing rare disease and immunology research. Christine also has over 20 years of experience as a lead researcher at Sirtris, Pfizer and ICOS Corporation, advancing several programs from concept to IND in autoimmunity, oncology and metabolic disease. She has a B.S. in biochemistry from Wellesley College and a Ph.D. in immunology from the Division of Medical Sciences at Harvard University.